This study reveals that TIL products expanded from pediatric neuroblastoma tumors exhibit anti-cancer capabilities, with γδ T cells as the primary active agents. #CancerResearch #Immunotherapy www.life-science-alliance.org/content/8/11...
Big promise by #gdTcells in pediatric cancer!
www.life-science-alliance.org/content/8/11...
Expanded TIL products generated from pediatric neuroblastoma lesions show anti-tumor potential, with γδ T cells identified as the main effector cells www.life-science-alliance.org/content/8/11...